术前抗胆碱能药物暴露与老年非心脏手术后资源利用及结局的关联:基于人群的队列研究
该回顾性人群队列研究纳入加拿大安大略省2003至2014年245,410例65岁以上择期非心脏大手术患者,用抗胆碱能风险量表(ARS)量化术前暴露。多变量模型显示较高ARS评分与更长住院时间、更低生存率、更高机构出院和再入院率及更高费用相关。
要点
- 术前ARS评分越高,老年择期非心脏大手术后住院时间越长。
- 较高ARS评分与更差生存、更高机构出院和再入院率及费用相关。
- 或需围术期干预研究以减少老年手术患者抗胆碱能暴露。
核心结论
- 术前抗胆碱能风险量表评分升高与老年择期非心脏大手术后住院时间延长、生存率降低、机构出院和再入院率升高及医疗费用增加相关。
研究设计与样本
- 回顾性、基于人群的队列研究,使用加拿大安大略省关联行政数据,纳入2003至2014年所有65岁以上接受择期非心脏大手术者,共245,410例。
主要发现
- 245,410例中71,569例有抗胆碱能暴露,ARS 1-2占15.6%,ARS≥3占13.6%。
- 中位住院时间为5天(四分位距3-7天)。
- 调整竞争风险、手术风险、人口学特征和合并症后,ARS 1-2与更长住院时间相关(调整HR 0.94,95%CI 0.93-0.95,P<0.0001)。
- ARS≥3与更长住院时间相关(调整HR 0.93,95%CI 0.91-0.95,P<0.0001)。
- 所有次要结局均观察到类似关联。
关键数值与推荐
- 抗胆碱能暴露用抗胆碱能风险量表(ARS)量化,分组为ARS 1-2和ARS≥3。
- 主要结局为住院时间,次要结局包括机构出院、再入院、费用和生存。
临床怎么用
- 对老年择期非心脏大手术患者,术前应评估抗胆碱能药物暴露(ARS评分),高评分者可能需优化用药并加强围术期资源规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to measure the association of preoperative anticholinergic exposure with length of stay (LOS) and other outcomes in older people having elective noncardiac surgery. SUMMARY BACKGROUND DATA: Anticholinergic medications are associated with adverse events in nonsurgical populations; the association of anticholinergic medications with outcomes in elective surgery patients is poorly described. METHODS: We conducted a retrospective, population-based cohort study using linked administrative data in Ontario, Canada. We identified all people >65 years old, from 2003 to 2014, having major, elective noncardiac surgery. Anticholinergic medication exposure was quantified using the Anticholinergic Risk Scale (ARS). Multilevel, multivariable modeling measured the adjusted association of ARS with LOS (primary outcome), institutional discharge, readmissions, costs, and survival (secondary outcomes). RESULTS: Of 245,410 individuals, 71,569 had anticholinergic exposure (ARS 1-2, 15.6%; ARS ≥3, 13.6%). Median LOS was 5 days (interquartile range 3-7). Using proportional hazards analysis to model time to discharge, adjusting for in-hospital death as a competing risk, and surgical risk, demographic characteristics, and comorbidities, higher ARS scores were associated with longer LOS [smaller hazard ratios (HRs) mean longer LOS; ARS 1-2: adjusted HR 0.94, 95% confidence interval (CI), 0.93-0.95, P < 0.0001; ARS ≥3: adjusted HR 0.93, 95% CI, 0.91-0.95, P < 0.0001]. Similar associations were observed for all secondary outcomes. CONCLUSIONS: Increasing ARS scores were associated with increased LOS, decreased survival, higher rates of institutional discharge and readmission, and higher costs of care. Perioperative interventional research to reduce the anticholinergic exposure in older surgical patients is likely warranted.
引用
- McIsaac DI, Wong CA, Diep D, et al. Association of Preoperative Anticholinergic Medication Exposure With Postoperative Healthcare Resource Use and Outcomes: A Population-based Cohort Study. Ann Surg. 2019. PMID: 29672409. doi:10.1097/SLA.0000000000002765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。